Stage IIA Prostate Cancer Completed Phase Trials for Ranolazine (DB00243)

IndicationStatusPhase
DBCOND0028878 (Stage IIA Prostate Cancer)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01992016A Pilot Study to Enhance F18 FDG-PET Imaging of Prostate Cancers With the Metabolic Inhibitor RanolazineDiagnostic